Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04913870
PHASE4
Angiotensin Receptor Blockers in Aortic Stenosis
Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
View on ClinicalTrials.gov
Summary
This study is intended to investigate the effect of angiotensin receptor blockers (ARBs) on mild-to-moderate aortic stenosis.
Official title: Impact of Angiotensin Receptor Blockers in Aortic Stenosis - a Randomized Controlled Trial
Key Details
Gender
All
Age Range
20 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
144
Start Date
2020-02-01
Completion Date
2027-02
Last Updated
2024-12-20
Healthy Volunteers
No
Conditions
Interventions
DRUG
Angiotensin Receptor Blockers
Angiotensin Receptor Blockers treatment for 2 years.
OTHER
Placebo
Placebo administration for 2 years.
Locations (2)
CRIUCPQ
Québec, Quebec, Canada
Odense University Hospital
Odense, Denmark